In exercise of the powers conferred by sub-section (1) of section 20 of the Drug Regulatory Authority of Pakistan Act,2012 (XXI of 2012), read with sub-rule (3) of Rule 4 of the Drug Regulatory Authority of Pakistan (Fee and Levy) Rules, 2022, the regulatory fees of various functions has been notified. The Notification as under:-
- Orientation Session For Pharmaceutical Manufacturers on PIC/s GMP Guidelines
- Minutes of 339th meeting of Registration Board held on 6th – 8th August, 2024